News & Event

2021년 February 18일

Column: Bora Kim, Program Associate of RIGHT Fund “Korea needs to grow interest in global public health market further”

Published in the Korea Biomedical Review & the Korean Doctors’ Weekly Bora Kim, Program Associate of Investment Management Team, RIGHT Fund     Global health is […]
2021년 January 22일

Interview: Myongsei Sohn, Chairman of the Board of Directors, RIGHT Fund “Support for Infectious Disease R&D Should Aim to Prepare for Future Disasters rather than an Immediate Result”

Published in the Joongang daily This article is only available in Korean.   Original Article  
2021년 January 21일

Interview: Myongsei Sohn, Chairman of the Board of Directors, RIGHT Fund “No reasons to reject post that can enhance Korea’s healthcare status”

Published in the Korea Biomedical Review & the Korean Doctors’ Weekly Former Yonsei University Professor Sohn Myong-sei, who served as director of the Health Insurance Review […]
2021년 January 1일

Interview: Myongsei Sohn, Chairman of the Board of Directors, RIGHT Fund “Korea’s Advanced Medical Technology Becomes Now the Hope of Developing Countries”

Published in the Yonsein monthly This article is only available in Korean.   Original Article  
2020년 November 30일

Interview: “SK Bioscience is Developing a Cost-Effective HAV Vaccine on a Small-Footprint, Low-Cost Vaccine Manufacturing Platform”

Published in the Yakup This article is only available in Korean.   Original Article  
2020년 November 23일

Interview: “QuadMedicine is developing the world’s first pentavalent vaccine microneedle system leveraging its MAP technology”

Published in the Yakup This article is only available in Korean.   Original Article  
2020년 November 16일

Interview: “EuBiologics will Contribute the Defeating Global Meningitis Through Development of the Quadrivalent Meningococcal Conjugate Vaccine”

Published in the Yakup This article is only available in Korean. Original Article  
2020년 November 13일

Featured News: Trevor Mundel, president of Global Health at the BMGF “Korea to play key role in fighting off future pandemics”

Published in the Korea Biomedical Review Korea will become an integral part of fighting off future pandemics with the nation’s accumulated experience from fighting Covid-19, according […]
2020년 November 13일

RIGHT Fund Investment Forum 2020

RIGHT Fund Investment Forum 2020 This year’s RIGHT Fund Investment Forum was held as the 2nd session of Healthcare Innovation Forum 2020 co-hosted by the ChosunBiz […]
2020년 November 12일

[RIGHT Fund Investment Forum 2020_HEALTHCARE INNOVATION FORUM 2020] The Pandemic Would Come Back Again… Should Break Through with Global Collaboration and Innovation

Published in the ChosunBiz This article is only available in Korean.   Original Article  
2020년 November 12일

[RIGHT Fund Investment Forum 2020_HEALTHCARE INNOVATION FORUM 2020] Baik Lin Seong, Director General, VITAL-Korea “We’ll Secure Vaccine Sovereignty to End the Pandemic”

Published in the ChosunBiz This article is only available in Korean.   Original Article  
2020년 November 12일

[RIGHT Fund Investment Forum 2020_HEALTHCARE INNOVATION FORUM 2020] Jin Seon Park, Vice President of SK Bioscience “Global Cooperation to Overcome the Pandemic Both Contributes for it and Shares the Risk”

Published in the ChosunBiz This article is only available in Korean.   Original Article  
2020년 November 12일

[RIGHT Fund Investment Forum 2020_HEALTHCARE INNOVATION FORUM 2020] Nathalie Strub-Wourgaft, Director of Neglected Tropical Diseases, DNDi “We Will Develop 14 Therapeutics for Africa in 10 Years”

Published in the ChosunBiz This article is only available in Korean.   Original Article  
2020년 November 12일

[RIGHT Fund Investment Forum 2020_HEALTHCARE INNOVATION FORUM 2020] In-Kyu Yoon, Vaccine Development Project Leader of CEPI “COVID-19 Vaccine Should be Distributed Evenly in the World”

Published in the ChosunBiz This article is only available in Korean.   Original Article  
2020년 November 12일

[RIGHT Fund Investment Forum 2020_HEALTHCARE INNOVATION FORUM 2020] Joan Herbert, Senior Director, Business Development of MMV “Hope to Share our Mission of a World Without Malaria with Korean Partners”

Published in the ChosunBiz This article is only available in Korean.   Original Article  
2020년 November 12일

[RIGHT Fund Investment Forum 2020_HEALTHCARE INNOVATION FORUM 2020] Catharina Boehme, Chief Executive Officer of FIND “Korean Diagnostic Kits Play the Key Role of COVID-19 Response”

Published in the ChosunBiz This article is only available in Korean.   Original Article  
2020년 November 12일

[RIGHT Fund Investment Forum 2020_HEALTHCARE INNOVATION FORUM 2020] Ajoy Chakrabarti, Portfolio & Platform Lead of BMGF “There’d be a Pandemic Once Every Generation… Make Vaccine Development a Much Bigger Priority Going Forward”

Published in the ChosunBiz This article is only available in Korean.   Original Article  
2020년 November 12일

[RIGHT Fund Investment Forum 2020_HEALTHCARE INNOVATION FORUM 2020] Bryan Yeung, Senior Director of Strategy, RIGHT Fund “What is Selection Priority of RIGHT Fund’s Supporting R&D for Infectious Disease?”

Published in the ChosunBiz This article is only available in Korean.   Original Article  
2020년 November 12일

[RIGHT Fund Investment Forum 2020_HEALTHCARE INNOVATION FORUM 2020] Younbeen Kim, CEO of RIGHT Fund “New RFP Open today”

Published in the ChosunBiz This article is only available in Korean.   Original Article  
2020년 November 12일

[RIGHT Fund Investment Forum 2020_HEALTHCARE INNOVATION FORUM 2020] Trevor Mundel, president of Global Health at the BMGF “Collaboration with Korean partners will become more important due to COVID-19”

Published in the ChosunBiz This article is only available in Korean.   Original Article  
2020년 November 12일

[RIGHT Fund Investment Forum 2020_HEALTHCARE INNOVATION FORUM 2020] COVID-19 Accelerates Innovation of the Bio-Healthcare Technology

Published in the ChosunBiz This article is only available in Korean.   Original Article  
2020년 November 12일

[RIGHT Fund Investment Forum 2020_HEALTHCARE INNOVATION FORUM 2020] Will Digital Health Technology Save Human Being?

Published in the ChosunBiz This article is only available in Korean.   Original Article  
2020년 November 12일

[RIGHT Fund Investment Forum 2020_HEALTHCARE INNOVATION FORUM 2020] “Vaccine Development” Unprecedented Global Cooperation

Published in the ChosunBiz This article is only available in Korean.   Original Article  
2020년 November 11일

Interview: “Development of a High-Sensitivity Diagnostic Platform Utilizing Semiconductor Technology”

Published in the Yakup This article is only available in Korean. Original Article  
2020년 November 9일

Interview: “Development of a Prime-Boost BCG Vaccine will be a New Milestone in Combating Tuberculosis”

Published in the Yakup This article is only available in Korean. Original Article  
2020년 November 4일

Interview: “Development of Rapid Diagnostic Test for Both Typhoid Fever and Paratyphoid Fever Through Differentiation Technology of Serotypes of ImmuneMed”

Published in the Yakup This article is only available in Korean. Original Article  
2020년 November 2일

Interview: “Solgent is Developing the G6PD POC Test Before Malaria Treatment to the Quantitative Kit Level”

Published in the Yakup This article is only available in Korean.   Original Article  
2020년 October 28일

Interview: “Raphas is Developing an Mpg Microarray Patch Tuberculosis Vaccine Equipped with Effectiveness, Safety, and Economy”

Published in the Yakup This article is only available in Korean. Original Article  
2020년 October 26일

Interview: “Noul is Developing an Integrated Solution for Diagnosis and Prevention to Eradicate Malaria, one of the World’s Top 3 of the Infectious Diseases”

Published in the Yakup This article is only available in Korean. Original Article  
2020년 October 20일

Interview: “Genexine is Developing an Innovative Vaccine Enhancing the Immune Response in future Pandemic”

Published in the Yakup This article is only available in Korean. Original Article  
2020년 October 19일

Interview: “Development of the method to administer COVID-19 DNA vaccines through QuadMedicine’s Technology”

Published in the Yakup This article is only available in Korean. Original Article  
2020년 October 14일

Interview: “SK Bioscience is Establishing Viral Vector Technology to respond to the 2nd Wave of COVID-19 Pandemic”

Published in the Yakup This article is only available in Korean. Original Article  
2020년 October 12일

Interview: “To Prevent the 2nd Wave of COVID-19 Pandemic is Necessary Establishment of the Mucosal Vaccine Platform by KCAV”

Published in the Yakup This article is only available in Korean.   Original Article  
2020년 October 7일

Interview: Younbeen Kim, CEO of RIGHT Fund “Established the Portfolio of 22 Technologies Tackling Infectious Diseases”

Published in the Medicalnews This article is only available in Korean. Original Article  
2020년 October 6일

Interview: “VUNO Develops COVID-19 X-ray diagnostic auxiliary solution by using its AI-based technology”

Published in the Yakup This article is only available in Korean.   Original Article  
2020년 October 5일

Interview: “Philmedi leads the development of universal molecular diagnostics technology that can prepare for the 2nd wave coronavirus pandemic”

Published in the Yakup This article is only available in Korean.   Original Article  
2020년 September 29일

Interview: “Precision Biosensor is developing a Mobile Diagnostic Platform by using its Time-Resolved Fluorescence for COVID-19”

Published in the Yakup This article is only available in Korean.   Original Article  
2020년 September 28일

Interview: “KT will Highly Develop a Epidemic Prevention Platform Through its Generic Technology on Digital Health”

Published in the Yakup This article is only available in Korean.   Original Article  
2020년 September 22일

Interview: Younbeen Kim, CEO of RIGHT Fund “Application of Korea’s Technological Strengths Towards Global Health Can Improve Healthcare Access in LMICs”

Published in the Medicalnews This article is only available in Korean. Original Article  
2020년 September 18일

Interview: Younbeen Kim, CEO of RIGHT Fund “Infectious Disease is a socio-economic hurdle and a humanity problem”

Published in the Medicalnews This article is only available in Korean. Original Article
2020년 September 11일

Interview: Joon Haeng Rhee, Member of the Selection Committee, RIGHT Fund “K-Bio Technical Skills are Enough…Need to Gain Experience on Global Health Market through Infectious Disease Research supporting by RIGHT Fund”

Published in the Maeil Business Newspaper. This article is only available in Korean. Original Article
2020년 September 3일

Interview: Leadership of three Korean life science companies starting contributing to RIGHT Fund this year “What are the backgrounds of partnerships with the RIGHT Fund”

Published in the Yakup. This article is only available in Korean. Original Article
2020년 August 26일

Interview: Chang Jin Moon, Chairman of the Board of Directors, RIGHT Fund “Infectious Disease is a Public-Health Problem… Support Research of Less-Profitable Areas for Human Health”

Published in the Dong-A Daily News This article is only available in Korean. Original Article
2020년 August 17일

Featured News: RIGHT Fund supports for the innovative COVID-19 vaccine research in Korea

Published in the Newsis. This article is only available in Korean. Original Article
2020년 July 31일

Featured News: RIGHT Fund gain momentum by letter of Bill Gates on expanding partnership with domestic companies?

Published in the Newsis. This article is only available in Korean. Original Article
2020년 July 28일

Featured News: RIGHT Fund joined in BMGF and SK Bioscience, supports ODA for developing countries

Published in the Hankyoreh. S. Korean biotech firms commit major investments into global vaccine research After Microsoft co-founder and philanthropist Bill Gates mentioned the possibility of […]
2020년 July 22일

Interview: Younbeen Kim, CEO of RIGHT Fund “All industrial funders of RIGHT Fund commit to overcoming infectious diseases despite the less-profitable structure”

This article is only available in Korean. Original Article
2020년 July 6일

Column: Bryan K.S. Yeung, Senior Director of Strategy, RIGHT Fund “The RIGHT approach for global health solutions”

Published in the HelloDD Dr. Bryan K.S. Yeung, Senior Director of Strategy, RIGHT Fund Infectious diseases remain a significant burden on the global community. The past […]
2020년 June 12일

RFP Web-seminar for Product Development Award

Please replay the recording of the latest RFP Web-seminar for Product Development Award. Replay
2020년 May 28일

Interview: Younbeen Kim, CEO of RIGHT Fund “Bill Gates was impressed with the amount of R&D for COVID-19 in K-Bio”

Published in the ChosunBiz This article is only available in Korean. Original Article
2020년 May 25일

Interview: Chang Jin Moon, Chairman of the Board of Directors, RIGHT Fund “COVID-19 return as a boomerang if we can’t control the disease in developing countries…Cooperation needed to supply low-cost vaccine”

Published in the Kookmin Ilbo This article is only available in Korean. Original Article
2020년 April 28일

Interview: Chang Jin Moon, Chairman of the Board of Directors, RIGHT Fund “Neglecting COVID-19 in developing countries, may result in a boomerang return effect”

Published in the Joongang Ilbo This article is only available in Korean. Original Article
2020년 April 27일

Interview: Younbeen Kim, CEO of RIGHT Fund “Korean research could play a pivotal role in the fight against infectious diseases”

Published in the HelloDD This article is only available in Korean. Original Article
2020년 April 21일

Interview: Younbeen Kim, CEO of RIGHT Fund “The public-private partnership is critical regarding the infectious disease research”

Published in the Dong-A Daily News This article is only available in Korean. Original Article
2020년 April 20일

Column: Younbeen Kim, CEO of RIGHT Fund “COVID-19 vaccine development is not only the responsibility of life science companies”

Published in the Korea Economic Daily, Hankyunghealth. This article is only available in Korean. Original Article
2020년 April 11일

Featured News: What is the RIGHT Fund which President Moon and Bill Gates mention, regarding the development the COVID19 vaccine?

Published in the Medicalnews This article is only available in Korean. Original Article  
2020년 April 2일

Interview: Paul Herrling, Chairman of the Selection Committee, RIGHT Fund “More public-private partnership needed to spur research of less-profitable areas”

Published in the Korea Biomedical Review & the Korean Doctors’ Weekly The new coronavirus pandemic has affected more than 800,000 people around the world as of […]
2020년 March 20일

Interview: Younbeen Kim, CEO of RIGHT Fund “The development of vaccines and therapeutics for COVID-19 shouldn’t be given up”

Published in the Maeil Business Newspaper This article is only available in Korean. Original Article
2020년 March 20일

RFP Web-Seminar for Technical Accelerator Award

Please replay the recording of the latest RFP Web-seminar for Product Development Award. Replay
2020년 March 16일

Interview: Chang Jin Moon, Chairman of the Board of Directors, RIGHT Fund “RIGHT Fund will provide active support for research on endemic and emerging infectious diseases such as COVID-19”

Published in the Hankook Ilbo This article is only available in Korean. Original Article
2020년 March 9일

Featured News: “The Government, Pharmaceutical companies and the Gates Foundation together support ODA, leveraging Korea’s innovation and strength”

Published in Online the Maeil Business Newspaper This article is only available in Korean.   Original Article
2020년 February 27일

Featured News: Blocking extensively drug-resistant tuberculosis prevent crisis of public health

Published in the The DOCTOR’S NEWS This article is only available in Korean. Original Article
2020년 February 26일

Featured News: New Diagnostic For Safe Administration of Malaria Drugs…Screening For G6PD Deficiency

Published in the The DOCTOR’S NEWS This article is only available in Korean. Original Article
2020년 February 23일

Featured News: The key of new single-dose antimalarial drug is a Continuous Process Development

PPublished in the The DOCTOR’S NEWS This article is only available in Korean. Original Article
2020년 February 21일

Featured News: Supply of hexavalent vaccines to developing countries could completely eradicate polio

Published in the The DOCTOR’S NEWS This article is only available in Korean. Original Article
2020년 February 19일

Featured News: Leveraging Korean’s technology in development of MGH-Harvard’s ‘Novel Cholera Conjugate Vaccine’

Published in the The DOCTOR’S NEWS This article is only available in Korean. Original Article
2020년 February 12일

Interview: Younbeen Kim, CEO of RIGHT Fund “RIGHT Fund Makes the Life Change”

RIGHT Fund Makes the Life Change Published in the The DOCTOR’S NEWS   This article is only available in Korean. Original Article
2020년 January 15일

Featured News: Global cooperation is critical in the war of humans and viruses

Published in the The Kyunghynag Daily This article is only available in Korean. Original Article
2019년 December 9일

Interview: Dr. Andrin Oswald, Director of The BMGF “Korea, Leading Country of Life Science is anticipated to contribute global health”

Korea, Leading Country of Life Science is anticipated to contribute global health Published in the Yakup.   This article is only available in Korean. Original Article
2019년 November 25일

Interview: Leadership of five Korean life science companies investing in RIGHT Fund “RIGHT Fund invests 50 billion… seeking of new vaccines and therapeutics”

RIGHT Fund invests 50 billion… seeking of new vaccines and therapeutics Published in the Yakup.   This article is only available in Korean.   Original Article
2019년 July 24일

Interview: Younbeen Kim, CEO of RIGHT Fund “Contribute to global public health leveraging Korean technology”

Published in the The Dailypharm   This article is only available in Korean.   Original Article
2019년 July 18일

Interview: Younbeen Kim, CEO of RIGHT Fund “RIGHT Fund aims to use Korean innovation for global health equity”

Korea Biomedical Review_RIGHT Fund aims to use Korean innovation for global health equity Infectious diseases remain a leading cause of deaths worldwide and have been disproportionately […]
2019년 July 17일

Featured News: “RIGHT Fund reveals 1st investment into public health projects in developing countries”

Korea Biomedical Review_RIGHT Fund reveals 1st investment into public health projects in developing countries Bryan Yeung, senior director of strategy at RIGHT Fund, announces plans for […]
2019년 July 17일

2019 RIGHT FUND INVESTMENT FORUM

2019년 February 6일

Column: Younbeen Kim, CEO of RIGHT Fund “there is no safe zone for infectious diseases in the era of globalization”

Published in the The Hankyoreh.   This article is only available in Korean.   Original Article
2018년 November 22일

Interview: Chang Jin Moon, Chairman of the Board of Directors, RIGHT Fund “Develop ODA models to help low income countries by developing incrementally modified drugs”

Published in the Korea Economic Daily, Hankyunghealth.   This article is only available in Korean.   Original Article